CLYM 8-K: SEC filing
Filed with the SEC on · accession 0001193125-26-448556
CLYM filed a 8-K (current report) with the SEC on Nov 5, 2026. Climb Bio, Inc. furnished an 8-K reporting its financial results for the quarter ended September 30, 2026, and published an updated corporate presentation. The stock moved -4.9% by the first close after the filing.
Summary of the filing
Climb Bio, Inc. furnished an 8-K reporting its financial results for the quarter ended September 30, 2026, and published an updated corporate presentation. The filing was made under Items 2.02 and 7.01 and includes a press release and investor presentation as exhibits.
Key details
How CLYM stock reacted
Close before
$9.33
Nov 4, 2026
First close after
-4.93%
$8.87
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CLYM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CLYM?
Click hereFrequently asked questions
What did CLYM file with the SEC on Nov 5, 2026?
CLYM filed a 8-K (SEC filing). Climb Bio, Inc. furnished an 8-K reporting its financial results for the quarter ended September 30, 2026, and published an updated corporate presentation. The filing was made under Items 2.02 and 7.01 and includes a press release and investor presentation as exhibits.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did CLYM stock react to this filing?
CLYM closed at $9.33 before the filing and $8.87 on Nov 5, 2026 (-4.93%).
Other CLYM SEC filings
- 10-Q · SEC filingNov 5, 2026
- 8-K · Fda approvalOct 26, 2026
- 8-K · Fda approvalOct 23, 2026
- 8-K · Fda approvalSep 3, 2026
- 8-K · SEC filingAug 14, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · SEC filingAug 6, 2026
- 8-K · Board changeJul 1, 2026
- 144 · Insider sale plannedJun 30, 2026
- 424B5 · Secondary offeringJun 12, 2026
Get alerts when CLYM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days